TEKT3
gene geneOn this page
Also known as FLJ32828
Summary
TEKT3 (tektin 3, HGNC:14293) is a protein-coding gene on chromosome 17p12, encoding Tektin-3 (Q9BXF9). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia and flagellar axoneme.
This gene product belongs to the tektin family of proteins. Tektins comprise a family of filament-forming proteins that are coassembled with tubulins to form ciliary and flagellar microtubules. The exact function of this gene is not known.
Source: NCBI Gene 64518 — RefSeq curated summary.
At a glance
- Gene–disease (curated): spermatogenic failure 81 (Limited, GenCC)
- GWAS associations: 2
- Clinical variants (ClinVar): 116 total — 4 pathogenic, 1 likely-pathogenic
- Phenotypes (HPO): 6
- MANE Select transcript:
NM_031898
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14293 |
| Approved symbol | TEKT3 |
| Name | tektin 3 |
| Location | 17p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32828 |
| Ensembl gene | ENSG00000125409 |
| Ensembl biotype | protein_coding |
| OMIM | 612683 |
| Entrez | 64518 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000338696, ENST00000395930, ENST00000395931, ENST00000462175, ENST00000470325, ENST00000536146, ENST00000539245, ENST00000539316, ENST00000543896, ENST00000578011
RefSeq mRNA: 1 — MANE Select: NM_031898
NM_031898
CCDS: CCDS11169
Canonical transcript exons
ENST00000395930 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000907757 | 15314087 | 15314230 |
| ENSE00000907758 | 15319077 | 15319147 |
| ENSE00000907759 | 15327992 | 15328075 |
| ENSE00001523283 | 15340028 | 15340061 |
| ENSE00002238894 | 15341518 | 15341597 |
| ENSE00003493961 | 15312259 | 15312481 |
| ENSE00003646159 | 15331007 | 15331614 |
| ENSE00003655868 | 15303812 | 15304152 |
| ENSE00003683664 | 15308664 | 15308818 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 92.92.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0916 / max 47.8150, expressed in 23 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164686 | 0.0856 | 23 |
| 164687 | 0.0060 | 2 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 92.92 | gold quality |
| right testis | UBERON:0004534 | 92.43 | gold quality |
| testis | UBERON:0000473 | 90.52 | gold quality |
| right uterine tube | UBERON:0001302 | 90.04 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.83 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.04 | gold quality |
| bronchus | UBERON:0002185 | 84.96 | gold quality |
| sperm | CL:0000019 | 79.25 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 73.11 | gold quality |
| adult organism | UBERON:0007023 | 72.97 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.15 | gold quality |
| endocervix | UBERON:0000458 | 70.16 | gold quality |
| left ovary | UBERON:0002119 | 69.48 | gold quality |
| fallopian tube | UBERON:0003889 | 68.54 | gold quality |
| right ovary | UBERON:0002118 | 68.21 | gold quality |
| left uterine tube | UBERON:0001303 | 68.08 | gold quality |
| right coronary artery | UBERON:0001625 | 67.73 | gold quality |
| ventricular zone | UBERON:0003053 | 67.18 | gold quality |
| tibial nerve | UBERON:0001323 | 67.04 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 66.94 | gold quality |
| cerebellar cortex | UBERON:0002129 | 66.84 | gold quality |
| ovary | UBERON:0000992 | 66.50 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 66.50 | gold quality |
| ganglionic eminence | UBERON:0004023 | 66.40 | gold quality |
| omental fat pad | UBERON:0010414 | 66.11 | gold quality |
| peritoneum | UBERON:0002358 | 66.04 | gold quality |
| cerebellum | UBERON:0002037 | 65.04 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 64.91 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 64.79 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 64.72 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.34 |
| E-GEOD-99795 | no | 20.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting TEKT3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-105-5P | 99.54 | 69.24 | 2060 |
| HSA-MIR-7853-5P | 99.54 | 69.30 | 2055 |
| HSA-MIR-149-5P | 99.25 | 67.16 | 1315 |
| HSA-MIR-501-5P | 98.77 | 68.88 | 1328 |
| HSA-MIR-500A-5P | 98.76 | 69.13 | 1241 |
| HSA-MIR-6824-5P | 97.41 | 68.43 | 583 |
| HSA-MIR-4278 | 95.28 | 65.49 | 351 |
| HSA-MIR-6789-5P | 94.05 | 66.19 | 285 |
Literature-anchored findings (GeneRIF, showing 1)
- Bi-allelic human TEKT3 mutations cause male infertility with oligoasthenoteratozoospermia owing to acrosomal hypoplasia and reduced progressive motility. (PMID:36708031)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tekt3 | ENSDARG00000045038 |
| mus_musculus | Tekt3 | ENSMUSG00000042189 |
| rattus_norvegicus | Tekt3 | ENSRNOG00000027212 |
| drosophila_melanogaster | CG17450 | FBGN0040028 |
| drosophila_melanogaster | CG32819 | FBGN0052819 |
| drosophila_melanogaster | CG32820 | FBGN0052820 |
Paralogs (5): TEKT2 (ENSG00000092850), TEKT5 (ENSG00000153060), TEKT4 (ENSG00000163060), TEKT1 (ENSG00000167858), (ENSG00000274847)
Protein
Protein identifiers
Tektin-3 — Q9BXF9 (reviewed: Q9BXF9)
All UniProt accessions (6): Q9BXF9, F5GZV8, F5H115, F5H4K1, F5H5M8, J3KPT7
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia and flagellar axoneme. Forms filamentous polymers in the walls of ciliary and flagellar microtubules. Required for normal sperm mobility.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules. Interacts with TEKT1, TEKT2, TEKT4 and TEKT5. Interacts with CCDC38.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme. Cytoplasmic vesicle. Secretory vesicle. Acrosome outer membrane.
Tissue specificity. Expressed in spermatozoa. Expressed in airway epithelial cells.
Post-translational modifications. N- and O-glycosylated. May be proteolytically processed during the epididymal transit of spermatozoa. Ubiquitinated, leading to its degradation. Deubiquitinated by USP16, promoting its stability.
Disease relevance. Spermatogenic failure 81 (SPGF81) [MIM:620277] A male infertility disorder due to oligoasthenoteratozoospermia and characterized by reduced progressive sperm motility. Patient spermatozoa exhibit acrosomal hypoplasia and detachment of the acrosome from the sperm head. The disease may be caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the tektin family.
RefSeq proteins (1): NP_114104* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000435 | Tektins | Family |
| IPR048256 | Tektin-like | Family |
Pfam: PF03148
UniProt features (18 total): glycosylation site 9, sequence variant 6, chain 1, coiled-coil region 1, sequence conflict 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7UNG | ELECTRON MICROSCOPY | 3.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BXF9-F1 | 85.97 | 0.73 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (9): 344, 7, 9, 10, 41, 86, 103, 111, 276
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 85 (showing top):
chr17p12, GOCC_SECRETORY_GRANULE, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS, GOBP_CELL_PROJECTION_ORGANIZATION, GOCC_ACROSOMAL_MEMBRANE, GOCC_CYTOPLASMIC_REGION, GOCC_SECRETORY_VESICLE, GOCC_MOTILE_CILIUM, GOCC_SPERM_PRINCIPAL_PIECE, GOCC_SPERM_MIDPIECE, GOCC_SECRETORY_GRANULE_MEMBRANE
GO Biological Process (4): flagellated sperm motility (GO:0030317), cilium assembly (GO:0060271), cilium movement involved in cell motility (GO:0060294), regulation of brood size (GO:0060378)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (16): acrosomal vesicle (GO:0001669), acrosomal membrane (GO:0002080), outer acrosomal membrane (GO:0002081), nucleus (GO:0005634), axonemal microtubule (GO:0005879), microtubule cytoskeleton (GO:0015630), sperm flagellum (GO:0036126), extracellular exosome (GO:0070062), axonemal A tubule inner sheath (GO:0160111), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cilium-dependent cell motility | 2 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| cilium movement | 1 |
| cell motility | 1 |
| multi-multicellular organism process | 1 |
| multicellular organismal reproductive process | 1 |
| biological regulation | 1 |
| binding | 1 |
| secretory granule | 1 |
| acrosomal vesicle | 1 |
| secretory granule membrane | 1 |
| acrosomal membrane | 1 |
| cytoplasmic vesicle membrane | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| cytoskeleton | 1 |
| 9+2 motile cilium | 1 |
| extracellular vesicle | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1308 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEKT3 | CD164L2 | Q6UWJ8 | 647 |
| TEKT3 | TCP11 | Q8WWU5 | 624 |
| TEKT3 | CDRT15 | Q96T59 | 580 |
| TEKT3 | CDRT4 | Q8N9R6 | 571 |
| TEKT3 | TVP23B | Q9NYZ1 | 540 |
| TEKT3 | KRTAP8-1 | Q8IUC2 | 478 |
| TEKT3 | CLGN | O14967 | 447 |
| TEKT3 | ARMC3 | Q5W041 | 443 |
| TEKT3 | CTXN3 | Q4LDR2 | 441 |
| TEKT3 | NME5 | P56597 | 435 |
| TEKT3 | AKAP3 | O75969 | 419 |
| TEKT3 | TVP23C | Q96ET8 | 418 |
| TEKT3 | COX10 | Q12887 | 417 |
| TEKT3 | A0A0A6YYB9 | A0A0A6YYB9 | 411 |
| TEKT3 | TGM4 | P49221 | 407 |
| TEKT3 | CABYR | O75952 | 407 |
IntAct
113 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRAF2 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TEKT3 | CALCOCO2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| GORASP2 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CALCOCO2 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TEKT3 | GORASP2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SPAG8 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.600 |
| TNS2 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RFX6 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT34 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAMAC | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ATN1 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEKT3 | KRTAP3-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP26-1 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPH1 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-1 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-5 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LASP1 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| INSC | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP15-1 | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASPG | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARID5A | TEKT3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (48): TEKT3 (Two-hybrid), TEKT3 (Two-hybrid), TEKT3 (Two-hybrid), TEKT3 (Two-hybrid), CLUH (Affinity Capture-MS), LIMD1 (Affinity Capture-MS), ZNF703 (Affinity Capture-MS), TYSND1 (Affinity Capture-MS), PITRM1 (Affinity Capture-MS), PRRC2A (Affinity Capture-MS), TEKT3 (Two-hybrid), TEKT3 (Two-hybrid), TEKT3 (Two-hybrid), TEKT3 (Two-hybrid), TEKT3 (Two-hybrid)
ESM2 similar proteins: A1A5Q4, A4IH82, A6H782, A7S8T5, F7F3Q2, G5E8A8, O35594, O46469, Q0E908, Q149S1, Q26648, Q29RL1, Q2T9Q6, Q2TA16, Q2TA38, Q2YDI7, Q32KZ9, Q3SYS9, Q4R353, Q4R5V1, Q4R7G7, Q4V8G8, Q5PPV2, Q5RHQ8, Q5U584, Q5XIJ8, Q6AXV2, Q6AYM2, Q6DFJ6, Q6DGZ3, Q6PE87, Q6X6Z7, Q8CI04, Q8IXS2, Q8IYR0, Q8VHI7, Q8WW24, Q8WYA0, Q922G7, Q95JU3
Diamond homologs: A6H782, F7F3Q2, G5E8A8, P86230, Q149S1, Q1W6C3, Q26648, Q2T9Q6, Q2TA38, Q2YDI7, Q32KZ9, Q4R353, Q4R5V1, Q4V8G8, Q5PPV2, Q6AXV2, Q6AYM2, Q6X6Z7, Q8WW24, Q8WZ33, Q922G7, Q969V4, Q96M29, Q99JD2, Q9BXF9, Q9DAJ2, Q9TTW3, Q9UIF3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 34 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 8 | 20.3× | 2e-07 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
116 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 4 |
| Likely pathogenic | 1 |
| Uncertain significance | 105 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (5)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2443973 | NM_031898.3(TEKT3):c.543_547delinsTTGA (p.Glu182_Arg183delinsTer) | Pathogenic |
| 2443974 | NM_031898.3(TEKT3):c.548G>A (p.Arg183Gln) | Pathogenic |
| 2443975 | NM_031898.3(TEKT3):c.752A>C (p.Gln251Pro) | Pathogenic |
| 598751 | Single allele | Pathogenic |
| 4849436 | NM_031898.3(TEKT3):c.734+1G>A | Likely pathogenic |
SpliceAI
1205 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:15308668:G:C | donor_gain | 1.0000 |
| 17:15308819:C:CC | acceptor_gain | 1.0000 |
| 17:15308819:C:CG | acceptor_loss | 1.0000 |
| 17:15308821:G:C | acceptor_gain | 1.0000 |
| 17:15312254:TTTAC:T | donor_loss | 1.0000 |
| 17:15312255:TTAC:T | donor_loss | 1.0000 |
| 17:15312256:TACC:T | donor_loss | 1.0000 |
| 17:15312257:A:AT | donor_loss | 1.0000 |
| 17:15312258:C:A | donor_loss | 1.0000 |
| 17:15312477:AGACA:A | acceptor_gain | 1.0000 |
| 17:15312478:GACA:G | acceptor_gain | 1.0000 |
| 17:15312479:ACA:A | acceptor_gain | 1.0000 |
| 17:15312480:CA:C | acceptor_gain | 1.0000 |
| 17:15312480:CAC:C | acceptor_gain | 1.0000 |
| 17:15312482:C:CC | acceptor_gain | 1.0000 |
| 17:15312482:C:CG | acceptor_loss | 1.0000 |
| 17:15312483:T:C | acceptor_loss | 1.0000 |
| 17:15314085:A:AC | donor_gain | 1.0000 |
| 17:15314086:C:CC | donor_gain | 1.0000 |
| 17:15314086:CGTTG:C | donor_gain | 1.0000 |
| 17:15328072:CTAC:C | acceptor_gain | 1.0000 |
| 17:15304148:CAAGG:C | acceptor_gain | 0.9900 |
| 17:15304151:GG:G | acceptor_gain | 0.9900 |
| 17:15304153:C:CC | acceptor_gain | 0.9900 |
| 17:15304888:C:A | donor_gain | 0.9900 |
| 17:15304892:TAA:T | donor_gain | 0.9900 |
| 17:15304893:AAA:A | donor_gain | 0.9900 |
| 17:15304928:T:TA | donor_gain | 0.9900 |
| 17:15308658:CCTTA:C | donor_loss | 0.9900 |
| 17:15308659:CTTAC:C | donor_loss | 0.9900 |
AlphaMissense
3234 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:15312462:A:G | W300R | 0.998 |
| 17:15312462:A:T | W300R | 0.998 |
| 17:15314182:T:A | K261N | 0.998 |
| 17:15314182:T:G | K261N | 0.998 |
| 17:15312460:C:A | W300C | 0.997 |
| 17:15312460:C:G | W300C | 0.997 |
| 17:15303980:G:T | R477S | 0.996 |
| 17:15312416:C:G | R315P | 0.996 |
| 17:15331140:C:G | R149P | 0.996 |
| 17:15314175:C:G | A264P | 0.995 |
| 17:15314204:A:G | L254P | 0.995 |
| 17:15331065:A:G | L174P | 0.995 |
| 17:15312408:A:G | S318P | 0.994 |
| 17:15314184:T:C | K261E | 0.994 |
| 17:15328040:T:A | R205S | 0.994 |
| 17:15328040:T:G | R205S | 0.994 |
| 17:15328050:C:G | R202P | 0.994 |
| 17:15331121:A:C | F155L | 0.994 |
| 17:15331121:A:T | F155L | 0.994 |
| 17:15331123:A:G | F155L | 0.994 |
| 17:15304023:T:A | K462N | 0.993 |
| 17:15304023:T:G | K462N | 0.993 |
| 17:15314183:T:A | K261I | 0.993 |
| 17:15327999:A:G | L219P | 0.993 |
| 17:15331141:G:T | R149S | 0.993 |
| 17:15331245:C:G | R114P | 0.993 |
| 17:15331291:A:G | W99R | 0.993 |
| 17:15331291:A:T | W99R | 0.993 |
| 17:15308713:G:T | R403S | 0.992 |
| 17:15308721:A:G | L400P | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000041739 (17:15316412 G>A,C), RS1000050600 (17:15322278 C>T), RS1000291032 (17:15310246 T>A,C,G), RS1000314703 (17:15307240 G>C), RS1000353338 (17:15304361 G>A), RS1000419373 (17:15340500 T>C), RS1000430140 (17:15338412 G>C,T), RS1000450455 (17:15340880 A>G,T), RS1000564172 (17:15313558 G>A), RS1000630009 (17:15327361 CATAA>C), RS1000654359 (17:15321138 T>C), RS1000686290 (17:15320521 A>G), RS1000736821 (17:15327309 A>G), RS1000769725 (17:15327552 A>C), RS1000948345 (17:15321013 A>T)
Disease associations
OMIM: gene MIM:612683 | disease phenotypes: MIM:118220, MIM:620277
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| spermatogenic failure 81 | Limited | Unknown |
Mondo (2): Charcot-Marie-Tooth disease type 1A (MONDO:0007309), spermatogenic failure 81 (MONDO:0859522)
Orphanet (1): Charcot-Marie-Tooth disease type 1A (Orphanet:101081)
HPO phenotypes
6 total (6 of 6 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000798 | Oligozoospermia |
| HP:0003251 | Male infertility |
| HP:0006321 | Multiple non-erupting secondary teeth |
| HP:0034011 | Reduced progressive sperm motility |
| HP:0034913 | Acrosomal hypoplasia |
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003818_84 | Resting heart rate | 7.000000e-14 |
| GCST004898_2 | Preterm birth (maternal effect) | 5.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003917 | premature birth |
| EFO:0005939 | parental genotype effect measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 3 |
| Benzo(a)pyrene | affects methylation, increases expression, increases methylation | 2 |
| bisphenol A | increases expression | 1 |
| potassium perchlorate | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
14 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT02579759 | PHASE3 | COMPLETED | Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) |
| NCT02600286 | PHASE2 | TERMINATED | Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A |
| NCT02967679 | PHASE2 | COMPLETED | SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study |
| NCT07140614 | PHASE1 | RECRUITING | A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A. |
| NCT01289704 | PHASE2/PHASE3 | UNKNOWN | Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A) |
| NCT06328712 | PHASE1/PHASE2 | RECRUITING | Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter) |
| NCT02357355 | Not specified | COMPLETED | Driving Ability in Patients With CMT 1A |
| NCT02596191 | Not specified | ACTIVE_NOT_RECRUITING | Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers |
| NCT03278093 | Not specified | UNKNOWN | Effect of Orthoses and Underfoot Vibration on Balance in Neuropathy |
| NCT06794489 | Not specified | RECRUITING | Longitudinal Biomarkers With Selected Outcome Measures In CMT |
| NCT07049588 | Not specified | RECRUITING | Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease |
| NCT07461896 | Not specified | RECRUITING | Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP |
| NCT07476365 | Not specified | RECRUITING | A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A) |
| NCT07570446 | Not specified | RECRUITING | AUTONOMOUS DISORDERS IN CMT |
Related Atlas pages
- Associated diseases: spermatogenic failure 81
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Charcot-Marie-Tooth disease type 1A, spermatogenic failure 81